CV Sciences, Inc. financial data

Symbol
CVSI on OTC
Industry
Pharmaceutical Preparations
Location
9530 Padgett Street, Suite 107, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CannaVEST Corp. (to 1/4/2016), Foreclosure Solutions, Inc. (to 11/30/2012)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 126 % +17.3%
Quick Ratio 92.5 % +37.7%
Debt-to-equity 222 % -46.8%
Return On Equity -89.9 % -299%
Return On Assets -27.9 % -420%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 181M shares +16.8%
Common Stock, Shares, Outstanding 181M shares +16.8%
Entity Public Float 6M USD 0%
Common Stock, Value, Issued 18K USD +20%
Weighted Average Number of Shares Outstanding, Basic 172M shares +13%
Weighted Average Number of Shares Outstanding, Diluted 172M shares +13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.8M USD +0.71%
Cost of Revenue 8.55M USD -6.17%
Research and Development Expense 144K USD -7.1%
Operating Income (Loss) -2.53M USD -252%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.53M USD +54.6%
Income Tax Expense (Benefit) -3K USD -100%
Net Income (Loss) Attributable to Parent -2.53M USD -335%
Earnings Per Share, Basic -0.01 USD/shares -200%
Earnings Per Share, Diluted -0.01 USD/shares -200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 611K USD -55.6%
Accounts Receivable, after Allowance for Credit Loss, Current 639K USD +4.58%
Inventory, Net 5.21M USD -10.8%
Assets, Current 6.73M USD -21.2%
Property, Plant and Equipment, Net 666K USD +45.7%
Operating Lease, Right-of-Use Asset 451K USD +103%
Intangible Assets, Net (Excluding Goodwill) 106K USD -57.8%
Goodwill 729K USD
Other Assets, Noncurrent 202K USD -49.6%
Assets 8.89M USD -10.1%
Accounts Payable, Current 2.31M USD +6.76%
Accrued Liabilities, Current 3.46M USD -2.15%
Liabilities, Current 6.03M USD +3.11%
Deferred Income Tax Liabilities, Net 19K USD +72.7%
Operating Lease, Liability, Noncurrent 233K USD +86.4%
Other Liabilities, Noncurrent 95K USD
Liabilities 6.38M USD +6.57%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2K USD
Retained Earnings (Accumulated Deficit) -85.8M USD -3.04%
Stockholders' Equity Attributable to Parent 2.51M USD -35.6%
Liabilities and Equity 8.89M USD -10.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -518K USD -153%
Net Cash Provided by (Used in) Financing Activities -136K USD +84.4%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 790M shares 0%
Common Stock, Shares, Issued 181M shares +16.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -655K USD -736%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 477K USD -71.8%
Deferred Tax Assets, Valuation Allowance 17M USD -3.73%
Deferred Tax Assets, Gross 17.1M USD -4.28%
Operating Lease, Liability 467K USD +88.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -591K USD +54.1%
Lessee, Operating Lease, Liability, to be Paid 523K USD +96.6%
Property, Plant and Equipment, Gross 1.43M USD +2.73%
Operating Lease, Liability, Current 234K USD +90.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 147K USD +149%
Lessee, Operating Lease, Liability, to be Paid, Year One 200K USD +43.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +28.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD +211%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37K USD
Deferred Tax Assets, Operating Loss Carryforwards 10.8M USD +16.4%
Preferred Stock, Shares Issued 1K shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 170K USD -1.16%
Additional Paid in Capital 88.3M USD +1.31%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4K USD
Depreciation, Depletion and Amortization 63K USD +6.78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%